Low total antioxidative capacity levels are associated with augmentation index but not pulse-wave velocity

Heart and Vessels

Volumn 24, Issue 5, 2009, Pages 366-370

  Gedikli, Omer ^a   Ozturk, Serkan ^a   Yilmaz, Hulya ^b   Baykan, Merih ^a   Kiris, Abdulkadir ^a   Durmus, Ismet ^b   Karaman, Kayhan ^a   Karahan, Caner ^b   Celik, Sukru ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b KTU Faculty of Medicine   (Turkey)

Author keywords

Hypertension; Pulse wave velocity; Total antioxidative capacity; Wave reflections

Indexed keywords

HYDROGEN PEROXIDE;

ADULT; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY PULSE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HEART RATE; HEART RHYTHM; HUMAN; HYPERTENSION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE WAVE; TONOMETRY; TOTAL ANTIOXIDATIVE CAPACITY;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CASE-CONTROL STUDIES; DOWN-REGULATION; ELASTICITY; FEMALE; FEMORAL ARTERY; HEART RATE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MANOMETRY; MIDDLE AGED; OXIDATIVE STRESS; PULSATILE FLOW; SPHYGMOMANOMETERS;

EID: 70349839487     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1129-7     Document Type: Article

References (34)

1. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236-1241
2. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension; 39:10-15
3. Hansen TW, Staessen J, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664-670
4. Nemes A, Forster T, Csanady M (2007) Simultaneous echocardiographic evaluation of coronary flow velocity reserve and aortic distensibility indices in hypertension. Heart Vessels 22:73-78
5. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H (2006) Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 27:2588-2605
6. Laurent S, Boutouyrie P (2007) Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 49:1202-1206
7. Romero JC, Reckelhoff JF (1999) Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34:943-949
8. Raij L (1998) Nitric oxide in hypertension: Relationship with renal injury and left ventricular hypertrophy. Hypertension 31:189-193
9. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R (1998) Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16:1267-1271
10. Goch A, Lewkowicz P, Tchorzewski H, Goch JH (2004) Serum total antioxidative capacity in patients with essential hypertension. Pol Merkur Lekarski. 17:564-566
11. Lacy F, O'Connor DT, Schmid-Schonbein GW (1998) Plasma hydrogen peroxide production in hypertensive and normotensive subjects at genetic risk of hypertension. J Hypertens 16:291-303
12. Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54:176-186
13. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK (1993) Free radicals and the heart. J Pharmacol Toxicol Methods 30:55-67
14. Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: Critical review and experimental data. Free Radic Biol Med 29:1106-1114
15. Demirbag R, Yilmaz R, Kunt AS, Gur M, Ulucay A, Unlu D (2006) Relationship between plasma total antioxidant capacity and thoracic aortic intima-media thickness. Echocardiography 23:183-188
16. Noma K, Goto C, Nishioka K, Jitsuiki D, Umemura T, Ueda K, Kimura M, Nakagawa K, Oshima T, Chayama K, Yoshizumi M, Liao JK, Higashi Y (2007) Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. J Am Coll Cardiol 49:698-705
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289:2560-2572
18. Pauca AL, O'Rourke MF, Kon ND (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38:932-937
19. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263-270
20. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Economou M, Papadimitriou L, Stefanadis C (2007) The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: The ATTICA study. Atherosclerosis 192:169-176
21. Nichols WW, MF O'Rourke (1998) McDonald's blood flow in arteries: theoretical, experimental and clinical principles. Arnold, London, 170-222
22. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, Toutouza M, Stefanadis C (2005) Acute systemic inflammation increases arterial stiffness and decreases wave reflection in healthy individuals. Circulation 112:2193-2200
23. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ (2001) Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 37:1429-1433
24. Tsuji T, Mizushige K, Noma T, Murakami K, Miyatake A, Kohno M (2002) Improvement of aortic wall distensibility and reduction of oxidative stress by pioglitazone in pre-diabetic stage of Otsuka Long-Evans Tokushima fatty rats. Cardiovasc Drugs Ther 16:429-434
25. Itoh S, Umemoto S, Hiromoto M, Toma Y, Tomochika Y, Aoyagi S, Tanaka M, Fujii T, Matsuzaki M (2002) Importance of NAD(P)H Oxidase-Mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Circulation 105:2288-2295
26. Meyer G, Merval R, Tedgui A (1996) Effects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. Circ Res 79:532-540
27. Inoue N, Kawashima S, Hirata KI, Rikitake Y, Takeshita S, Yamochi W, Akita H, Yokoyama M (1998) Stretch force on vascular smooth muscle cells enhances oxidation of LDL via superoxide production. Am J Physiol 274:1928-1932
28. Di Massimo C, Lo Presti R, Corbacelli C, Pompei A, Scarpelli P, De Amicis D, Caimi G, Tozzi Ciancarelli MG (2006) Impairment of plasma nitric oxide availability in senescent healthy individuals: Apparent involvement of extracellular superoxide dismutase activity. Clin Hemorheol Microcirc 35:231-237
29. Di Massimo C, Scarpelli P, Di Lorenzo N, Caimi G, di Orio F, Ciancarelli MG (2006) Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci 9;78:1163-1167
30. Landmesser U, Drexler H (2007) Endothelial function and hypertension. Curr Opin Cardiol 22:316-320
31. Harangi M, Remenyik E, Seres I, Varga Z, Katona E, Paragh G (2002) Determination of DNA damage induced by oxidative stress in hyperlipidemic patients. Mutat Res 513:17-25
32. Negishi H, Ikeda K, Kuga S, Noguchi T, Kanda T, Njelekela M, Liu L, Miki T, Nara Y, Sato T, Mashalla Y, Mtabaji J, Yamori Y (2001) The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J Hypertens 19:529-533
33. Demirbag R, Yilmaz R, Kocyigit A (2005) Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 570:197-203
34. Demirbag R, Yilmaz R, Gur M, Kocyigit A, Celik H, Guzel S, Selek S (2005) Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res 578:298-307